recombinant Isfahan virus-vectored trivalent vaccine(Auro Vaccines/Emergent Biosolutions)

N/A

Report date: 2025/01/26 17:44:02

Base Information

Drug Namerecombinant Isfahan virus-vectored trivalent vaccine(Auro Vaccines/Emergent Biosolutions)
Drug Alias Namerecombinant Isfahan virus-vectored trivalent vaccine (Profectus BioSciences/University of Texas Medical Branch at Galveston)recombinant Isfahan virus-vectored trivalent vaccine (Profectus BioSciences/University of Texas Medical Branch at Galveston)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsWestern equine encephalitis virus infectionEastern equine encephalitis virus infectionEncephalomyelitis, Venezuelan Equine
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesAuro Vaccines LlcEmergent Biosolutions Inc
Inactive CompaniesUniversity Of Texas Medical Branch +[2] 
Active IndicationsWestern equine encephalitis virus infectionEastern equine encephalitis virus infectionEncephalomyelitis, Venezuelan Equine
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A